To include your compound in the COVID-19 Resource Center, submit it here.

Gilead, Cadila Pharmaceuticals, Cipla, Hetero Drugs, Mylan, Ranbaxy, SeQuent Scientific, Strides Arcolab deal

Gilead signed non-exclusive licensing agreements allowing seven generic manufacturers to produce and market its chronic HCV drugs sofosbuvir and sofosbuvir/ledipasvir in 91 developing countries. Gilead said the deals are part of

Read the full 317 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers